Do you have any queries?

or Call us now at 9982-782-555

basket icon
Basket
(0 items)
back-arrow-image Search Health Packages, Tests & More

Leukemia Panel - Ph-like B-ALL, Bone Marrow

Also known as: Leukemia Panel-Ph like B-ALL by FISH, Heparin Blood**

50+ booked in last 3 days

Overview

The Leukemia Panel for Ph-like B-cell Acute Lymphoblastic Leukemia (Ph-like B-ALL) is a specialized diagnostic test performed on bone marrow samples to detect the presence of genetic abnormalities resembling the BCR-ABL1 fusion in ALL. This panel plays a crucial role in identifying Ph-like B-ALL cases and determining their prognosis, enabling tailored treatment strategies.
Read More

Leukemia Panel-Ph like B-ALL by FISH, Heparin Blood** Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Leukemia Panel-Ph like B-ALL by FISH, Heparin Blood** with a clear pricing structure.

The Leukemia Panel-Ph like B-ALL by FISH, Heparin Blood** Price in Mumbai is ₹ 19,950 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

The Leukemia Panel assesses the genetic makeup of leukemia cells to identify B-cell precursor ALL (B-ALL) cases with genetic alterations similar to BCR-ABL1 fusion, known as Philadelphia chromosome-like (Ph-like) ALL. It helps detect specific genetic abnormalities driving leukemia development.
• Accurate Diagnosis: Ph-like B-ALL cases are characterized by genetic abnormalities similar to BCR-ABL1 fusion, affecting treatment response and prognosis. • Prognostic Marker: Identification of Ph-like B-ALL aids in predicting the disease's behavior and guiding treatment decisions.
The Leukemia Panel for Ph-like B-ALL is recommended for: • Pediatric and adult patients diagnosed with B-cell precursor ALL. • Individuals suspected of having Ph-like B-ALL based on clinical and laboratory findings. • Patients for whom identifying Ph-like B-ALL could impact treatment choices and prognosis.
A positive result indicates the presence of genetic alterations resembling the BCR-ABL1 fusion in leukemia cells. This finding influences treatment decisions and helps predict disease behavior and response.
The test involves analyzing bone marrow samples for genetic abnormalities using advanced molecular techniques.
Specific instructions from healthcare providers should be followed before the procedure.
Cytogenetic Analysis: This test examines the chromosomes of leukemia cells for abnormalities, providing information about chromosomal rearrangements and identifying specific cytogenetic markers associated with different leukemia subtypes. Flow Cytometry: Flow cytometry is used to analyze the cell surface markers of leukemia cells, helping to determine their lineage and subtype. It aids in accurate classification and diagnosis. Minimal Residual Disease (MRD) Testing: MRD testing assesses the presence of residual leukemia cells in the bone marrow after treatment. It provides valuable information about treatment response and risk of relapse.
• B-ALL Ph-like Genetic Testing • Ph-like ALL Genetic Panel
full medical check up

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

lab image
170+ Advanced Labs
lab image
Trusted by Leading Doctors & Hospitals
lab images
Over 2000+ Scientific Officers
reports image
Proficiency Testing for Accurate Reports

Our Blog

Take a look at some of the related content from our blog

Latest Blogs & News

View More
View all